Pages that link to "Q54539679"
Jump to navigation
Jump to search
The following pages link to The 5q- syndrome: biology and treatment. (Q54539679):
Displaying 8 items.
- Lenalidomide: a review of its use in patients with transfusion-dependent anaemia due to low- or intermediate-1-risk myelodysplastic syndrome associated with 5q chromosome deletion (Q33408873) (← links)
- Current therapy of myelodysplastic syndromes (Q34013796) (← links)
- Myelodysplastic syndromes: toward a risk-adapted treatment approach (Q38149315) (← links)
- Standardizing the initial evaluation for myelodysplastic syndromes (Q38157706) (← links)
- Myelodysplastic syndromes with 5q deletion: pathophysiology and role of lenalidomide (Q38195796) (← links)
- Fungal Ribotoxins: A Review of Potential Biotechnological Applications. (Q39147928) (← links)
- Biological activity of lenalidomide in myelodysplastic syndromes with del5q: results of gene expression profiling from a multicenter phase II study. (Q44850006) (← links)
- Lenalidomide for myelodysplastic syndromes with del(5q): how long should it last? (Q50556796) (← links)